Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Change in Accured Expenses (2021 - 2025)

Zymeworks' Change in Accured Expenses history spans 3 years, with the latest figure at -$22.3 million for Q4 2023.

  • For Q4 2023, Change in Accured Expenses fell 159.42% year-over-year to -$22.3 million; the TTM value through Dec 2023 reached -$44.8 million, down 269.15%, while the annual FY2025 figure was -$23.6 million, 265.13% down from the prior year.
  • Change in Accured Expenses for Q4 2023 was -$22.3 million at Zymeworks, down from -$4.9 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $37.6 million in Q4 2022 and bottomed at -$28.3 million in Q1 2023.
  • The 3-year median for Change in Accured Expenses is $1.7 million (2022), against an average of -$1.4 million.
  • The largest annual shift saw Change in Accured Expenses surged 551.75% in 2022 before it crashed 339.14% in 2023.
  • A 3-year view of Change in Accured Expenses shows it stood at $5.8 million in 2021, then soared by 551.75% to $37.6 million in 2022, then crashed by 159.42% to -$22.3 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Change in Accured Expenses are -$22.3 million (Q4 2023), -$4.9 million (Q3 2023), and $10.7 million (Q2 2023).